Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
Resistance to cancer therapy remains a significant obstacle in treating patients with various solid malignancies. Exposure to current chemotherapeutics and targeted agents invariably leads to therapy resistance, heralding the need for novel agents. Cancer stem cells (CSCs)—a subpopulation of tumor c...
Main Authors: | Mudra, Sarah E., Sadhukhan, Pritam, Ugurlu, M. Talha, Alam, Shorna, Hoque, Mohammad O. |
---|---|
Format: | Article |
Published: |
Multidisciplinary Digital Publishing Institute
2021
|
Online Access: | https://hdl.handle.net/1721.1/133177 |
Similar Items
-
Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
by: Mudra, Sarah E., et al.
Published: (2022) -
PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers
by: Nobendu Mukerjee, et al.
Published: (2025-12-01) -
Head and neck cancer: pathogenesis and targeted therapy
by: Yan Liu, et al.
Published: (2024-09-01) -
Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.
by: Young Pil Kim, et al.
Published: (2014-01-01) -
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation
by: Kristina Vukovic Derfi, et al.
Published: (2024-12-01)